ENTRY       D11838                      Drug
NAME        Vilobelimab (USAN);
            Gohibic (TN)
PRODUCT
  OTHER     GOHIBIC (InflaRx GmbH)
FORMULA     C6456H9976N1716O2054S44
EXACT_MASS  145815.6633
MOL_WEIGHT  145905.4134
SEQUENCE    (Heavy chain)
            QVQLQQSGPQ LVRPGTSVKI SCKASGYSFT TFWMDWVKQR PGQGLEWIGR IDPSDSESRL
            DQRFKDRATL TVDKSSSTVY MQLSSPTSED SAVYYCARGN DGYYGFAYWG QGTLVTVSSA
            STKGPSVFPL APCSRSTSES TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTKTY TCNVDHKPSN TKVDKRVESK YGPPCPSCPA PEFLGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSQEDP EVQFNWYVDG VEVHNAKTKP REEQFNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKGLPSS IEKTISKAKG QPREPQVYTL PPSQEEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSRLT VDKSRWQEGN
            VFSCSVMHEA LHNHYTQKSL SLSLGK
            (Light chain)
            DIVLTQSPAS LAVSLGQRAT ISCKASQSVD YDGDSYMKWY QQKPGQPPKL LIYAASNLQS
            GIPARFSGSG SGTDFTLNIH PVEEEDAATY YCQQSNEDPY TFGGGTKLEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H96, H133-L218, H146-H202, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'133-L'218, H'146-H'202, H'260-H'320, H'366-H'424, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
REMARK      Product: D11838<US>
EFFICACY    Anti-inflammatory, Anti-complement C5a antibody
  DISEASE   Coronavirus disease 2019 [DS:H02398]
  TYPE      Monoclonal antibody
COMMENT     FDA has issued an EUA for the emergency use of GOHIBIC for the treatment of coronavirus disease 2019 (COVID-19)Treatment of hidradenitis suppurativa, ANCA- associated vasculitis, pyoderma gangrenosum and chronic inflammatory conditions
TARGET      C5 (C5a) [HSA:727] [KO:K03994]
  PATHWAY   hsa04610(727)  Complement and coagulation cascades
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Complement and coagulation
                C5 (C5a)
                 D11838  Vilobelimab (USAN) &lt;US&gt;
DBLINKS     CAS: 2250440-41-4
///
